Cancer

Thyroid Cancer Diagnosis Redefined with AI-Powered Biomarker

A new study introduces a dynamic biomarker system to improve early risk detection in differentiated thyroid carcinoma (DTC).

Cancer

Test Predicts Which Patients Will Not Respond to Chemotherapy

Researchers have developed genomic biomarkers to predict cancer patients’ resistance to chemotherapy, enabling more personalized treatment.

Cancer

Collaboration Expanded to Accelerate Progress in MASH Diagnosis

Echosens and Boehringer Ingelheim have expanded their partnership to improve early detection, diagnosis, and care access for MASH.

PREDICT DNA and SCANDARE Study Results Unveiled

Jun 3, 2025 | Breast

Personalis, Inc. unveiled promising new clinical data from the PREDICT DNA and SCANDARE studies at ASCO 2025.

ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening

Jun 2, 2025 | Colorectal

New Day Diagnostics has launched ColoHealth, a physician-mediated blood test for colorectal cancer screening.

Labcorp Expands Oncology Portfolio

May 30, 2025 | Cancer

Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers to support diagnostic development.

MRD Detection Gets New Standard with Pathlight

May 29, 2025 | Breast

SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.

Breast Cancer Index Test Data Reinforces Efficacy

May 28, 2025 | Breast

Hologic and Biotheranostics unveiled new data showing that the Breast Cancer Index (BCI) test improves treatment decision-making.

Independent Validation of CLARITY MRD Assay Presented

May 22, 2025 | Lymphoma

Foresight Diagnostics announced the independent validation of its CLARITY MRD assay, showing strong prognostic performance.

Partnership to Accelerate Development of Ovarian Cancer Test

May 22, 2025 | Unknown Origin & Other Cancer Types

A strategic partnership has formed to accelerate the development a test for early ovarian cancer diagnosis using AI-powered analytics.

AI Blood Test Could Be Key to Measure Pancreatic Cancer Therapy Success

May 21, 2025 | Pancreatic

Researchers developed an AI-driven blood test, ARTEMIS-DELFI, that detects pancreatic cancer treatment response faster and more accurately.

Roche Receives FDA Nod for Lung Cancer Companion Diagnostic

May 20, 2025 | Lung Cancer

The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.

Study IDs Two New Breast Cancer Genes in Black Women

May 15, 2025 | Breast

A groundbreaking genetic study identified two novel breast cancer-linked genetic variants in Black South African women.

Oncologists: More Advanced Cancers, Current Tests Not Catching Cancer Recurrence Early Enough

May 13, 2025 | Cancer

Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.

At-Home Self-Collection Device for Cervical Cancer Screening Gets FDA Approval

May 12, 2025 | Cervical (HPV)

Teal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.

Algorithms Can Help Predict Undiagnosed Cancer

May 7, 2025 | Cancer

New predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.

Ibex Breast Demonstrates High Accuracy, Efficiency in Study

May 6, 2025 | Breast

A new peer-reviewed study confirms that Ibex Breast significantly enhances accuracy, speed, and efficiency of breast pathology evaluations.

Breakthrough Device Designation Granted for Roche’s VENTANA TROP2 RxDx Device

May 5, 2025 | Lung Cancer

Roche’s VENTANA TROP2 RxDx Device, a computational companion diagnostic, has received FDA Breakthrough Device Designation.

Category: Cancer

Cancer

Cancer

Cancer